According to Weill Cornell researchers, epidemiological models of COVID-19 should take into account the special dynamics of the coronavirus’s spread in nursing homes and other long-term care facilities.
Sixteen faculty and professional staff members in state contract colleges at Cornell are receiving the 2019-20 State University of New York Chancellor’s Awards for Excellence.
Bacteria are growing increasingly antibiotic-resistant, but new research reveals how certain enzymes could be exploited to develop new classes of drugs to fight bacterial infections.
Cornell researchers combined genetic engineering, single-molecule tracking and protein quantitation to get a closer look at how living bacteria identify – and then build resistance to – toxic chemicals and metals. The knowledge could lead to the development of more effective antibacterial treatments.
The Cornell College of Veterinary Medicine is asking for human volunteers for a study into undiagnosed exposures to SARS-CoV-2, the virus that causes COVID-19, in the local community.
The commercialization of a Cornell-created antimicrobial coating technology that keeps surfaces clean by extending the life of chlorine-based disinfectants – by days and even weeks – is being fast-tracked to determine how well it can combat COVID-19.
